Following Decisions were Taken- 1.Considered, approved and took on record the unaudited Financial Results of the Company for the quarter ended on 30th June 2025 along with the Limited Review Report.
Awaiting price reaction for this filing.
Soni Medicare Ltd's board, at its meeting on August 14, 2025, approved the unaudited financial results for Q1 FY26 (quarter ended June 30, 2025). Revenue from operations came in at Rs. 727.71 lakhs, a modest increase of about 2.7% compared to Rs. 708.27 lakhs in the same quarter last year. Total expenses rose to Rs. 778.55 lakhs, exceeding total income of Rs. 749.20 lakhs, leading to a loss before tax of Rs. 29.35 lakhs. The net loss for the quarter stood at Rs. 29.10 lakhs, an improvement from the Rs. 86.63 lakh loss in Q1 FY25. Basic and diluted EPS was Rs. -0.68 versus Rs. -2.03 in the year-ago period. The statutory auditor, Tambi Ashok & Associates, issued a clean (unqualified) limited review report.
While the narrowing of losses is encouraging, the company is still reporting a net loss with expenses outpacing income, so shareholders should monitor whether the improvement is sustained and whether the company can return to profitability in upcoming quarters.